Saturday, October 3, 2026

Peloton Stock Is 23% Down In The Last 14 Days

Shares of Peloton slid by a staggering 23.71% in 14 days from $76.22 to $99.93 at 20:32 EST on Wednesday, after three successive sessions in a row of losses. NASDAQ Composite is rising 1.19% to $13,950.22, after two consecutive sessions in a row of losses. This seems, so far, an all-around positive trend trading session today.

Peloton's last close was $106.50, 71.21% below its 52-week high of $171.09.

The company's growth estimates for the current quarter is 40% and a drop 92.6% for the next.

Peloton's Revenue

Year-on-year quarterly revenue growth grew by 128.4%, now sitting on 2.95B for the twelve trailing months.

Peloton's Stock Yearly Top and Bottom Value

Peloton's stock is valued at $99.93 at 20:32 EST, way below its 52-week high of $171.09 and way higher than its 52-week low of $26.06.

Peloton's Moving Average

Peloton's value is way under its 50-day moving average of $115.23 and way under its 200-day moving average of $124.87.

Previous days news about Peloton

Look out: inflation impact on earnings, Peloton treadmills, cryptocurrency bubble concerns to drive volatility. According to FX Empire on Monday, 19 April, "Peloton in a response to the regulator's statement said it was "troubled by the CPSC's unilateral press release about the Peloton Tread+ because it is inaccurate and misleading.", "The regulator said it was aware of 39 incidents including one death and was investigating all known incidents related to the Peloton Tread+."

Peloton says CPSC report warning consumers to stop using tread+ is 'inaccurate and misleading'. According to MarketWatch on Monday, 19 April, "Peloton invited CPSC to make a joint announcement about the danger of not following the warnings and safety instructions provided with the Tread+, and [Chief Executive John] Foley asked to meet directly with CPSC," Peloton said."

Peloton faces mounting pressure to recall treadmills. According to The Wall Street Journal on Monday, 19 April, "Pressure mounted on Peloton Interactive Inc. on Monday when the chair of a House consumer-protection subcommittee called on the company to recall its treadmills.", "The videos and reports of children being sucked under Peloton treadmills are harrowing, and they graphically illustrate the grave and immediate risks these products pose to users and their families," Ms. Schakowsky said."

More news about Peloton.

Categories

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com